Florida-based biopharmaceutical company Oragenics, Inc. (OTCBB: ORNID) announced that it will feature the company’s ProBiora3® oral care probiotic ingredient at Supply Side West, October 19 – 23, 2010 in Las Vegas, NV…
Social Bookmarking
|
|||||
|
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported… Social Bookmarking EDI Health Group, Inc., (EHG), parent company of dentalXChange, a provider of enhanced connectivity, streamlined technology and transaction solutions for patients, payers and providers in the dental industry, has been selected by dentalOne Partners, Inc… Social Bookmarking OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September… Social Bookmarking University of Michigan School of dentistry has signed an agreement with Interleukin Genetics Inc. to conduct what may be the largest clinical study to date using genetic testing to assess the risk for gum disease. William Giannobile, professor at U-M dentistry and director of the Michigan Center for Oral Health Research at the School . . . → Read More: Genetic Test Used By Landmark Dental School Study To Help Predict Gum Disease  Leave a comment  Dental Health  agreement, date, Dental, dental school, director, disease, Genetic, genetic test, genetic testing, gum, gum disease, Inc, Interleukin, interleukin genetics inc, michigan center, michigan school, oral health research, school of dentistry, University, university of michigan school of dentistry The dentists who form Millennium dental Technologies, Inc. (MDT), and are pioneers of the patented LANAP™ protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser, released a statement questioning the Academy of General dentistry’s (AGD) priorities… Social Bookmarking Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) announced that Maxisal, its dietary supplement to enhance salivary function, promote oral comfort and help relive dry mouth, has been launched in Germany (www.Maxisal.de). Maxisal is marketed in Germany by ABI’s licensee Egofocus OHG based in Darmstadt. The first target market in Germany is cancer patients… Social Bookmarking In a statement today, StemSave™ Inc., the market leader in the field of stem cell recovery and cryo-preservation lauds research published in the current issue of the Journal of dental Research citing a new technique pioneered by the authors that can orchestrate the body’s own stem cells to regenerate teeth. StemSave commends the authors . . . → Read More: Study Published In Journal Of Dental Research: Body’s Own Stem Cells Leads To Tooth Regeneration |
|||||
|
Copyright © 2012 The North American Dental Implant Centers Blog - All Rights Reserved |
|||||
